<DOC>
	<DOCNO>NCT00685009</DOCNO>
	<brief_summary>Excessive memory decline dementia affect increase number woman become old . The frequency dementia double every 5 year begin age 60 , make discovery way prevent slow disease imperative . Previous study indicate change memory may associate female hormonal decline occur menopause , research need establish link menopause poor memory function . It believe take female hormone estrogen and/or progesterone may help improve woman 's health protect memory decline . This study evaluate effect female hormone replacement therapy ( HRT ) development progression memory loss old woman enrol Women 's Health Initiative ( WHI ) study .</brief_summary>
	<brief_title>The Women 's Health Initiative Memory Study ( The WHIMS Study )</brief_title>
	<detailed_description>Diseases memory , include dementia Alzheimer 's disease , primary health concern age population . In last 30 year , number Americans diagnosed memory disease double . The beginning sign symptoms Alzheimer 's dementia include mild forgetfulness , confusion , disorientation time place . As disease advance , people often experience difficulty carry normal activity , recognize family friend , eventually speak comprehend . Early identification treatment dementia Alzheimer 's may help prevent slow progression symptom , beneficial mean treatment still unknown . Previous study suggest link menopause reduce memory function woman , possibly attribute dramatic decline level female hormone estrogen progesterone . HRT postmenopausal woman may help curb memory loss reduce risk develop memory-related disease . This study evaluate effect female HRT development progression memory loss old woman enrol WHI study . Participants study draw WHI study previously assign HRT estrogen , HRT estrogen plus progesterone , placebo . During study , participant continue take assigned treatment WHI study . Participation last 6 year . All participant undergo baseline memory thinking test , include mood assessment task measure memory brain function . Study staff conduct telephone interview close family member friend . Some participant may additionally undergo 45-minute interview clinician , blood draw , computerize tomography ( CT ) scan . All participant repeat baseline memory thinking test annually 6 year , participant repeat interview , blood draw , CT scan annual visit well .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>Enrolled Women 's Health Initiative Hormone Therapy Trial Aged 65 79 year age time enrollment</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Cognition</keyword>
	<keyword>Memory</keyword>
	<keyword>Hormone Therapy</keyword>
</DOC>